Spigot opens on FY ’09 money
President Obama signs fiscal year 2009 omnibus appropriations bill March 11. FDA will have $2.6 billion to spend this fiscal year, including $777.4 million for CDER and related field activities, with $41.4 million reserved for the Office of Generic Drugs and $271.5 million for CBER and related field activities
You may also be interested in...
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.
Pharma pays $50m up front to tap insitro’s in vitro modeling technology, partners with Sensyne Health in blood disorders. Lilly’s COVID-19 partner AbCellera teams with Kodiak in ophthalmology R&D.